Index by author

August 1, 2023; Volume 64,Issue 8

  1. Eberhardt, Wilfried

    1. SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
      SUVmax Above 20 in 18F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
      Gregor Zaun, Manuel Weber, Martin Metzenmacher, Marcel Wiesweg, Thomas Hilser, Yasmin Zaun, Sven Liffers, Michael Pogorzelski, Isabel Virchow, Wilfried Eberhardt, Sarah Theurer, Tanja Abu Sabbah, Timm M. Reissig, Martin Stuschke, Cornelius Kürten, Timon Hussain, Stephan Lang, Stefan Kasper, Wolfgang P. Fendler, Ken Herrmann and Martin Schuler
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1191-1194; DOI: https://doi.org/10.2967/jnumed.122.265161

  2. Eckstein, Anja

    1. Evaluation of [<sup>68</sup>Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space
      Evaluation of [68Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space
      Aleksandar Milosevic, Hanna Styczen, Johannes Grueneisen, Yan Li, Manuel Weber, Wolfgang P. Fendler, Julian Kirchner, Philipp Damman, Karsten Wrede, Lazaros Lazaridis, Martin Glas, Maja Guberina, Anja Eckstein, Tobias Blau, Ken Herrmann, Lale Umutlu, Michael Forsting, Cornelius Deuschl and Benedikt Schaarschmidt
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1185-1190; DOI: https://doi.org/10.2967/jnumed.123.265424

  3. Eguchi, Hidetoshi

    1. Initial Evaluation of [<sup>18</sup>F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
      Open Access
      Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
      Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1225-1231; DOI: https://doi.org/10.2967/jnumed.123.265486

  4. Eiber, Matthias

    1. Safety and Efficacy of [<sup>177</sup>Lu]-PSMA-I&amp;T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
      Safety and Efficacy of [177Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
      Robert Tauber, Karina Knorr, Margitta Retz, Isabel Rauscher, Sonia Grigorascu, Kimberley Hansen, Calogero D’Alessandria, Hans-Jürgen Wester, Jürgen Gschwend, Wolfgang Weber, Matthias Eiber and Thomas Langbein
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1244-1251; DOI: https://doi.org/10.2967/jnumed.122.265259
    2. Reply: PSMA Is Not Specific to Prostate Cancer
      Susan Notohamiprodjo, Matthias Eiber, Christian Lohrmann and Wolfgang A. Weber
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1326-1327; DOI: https://doi.org/10.2967/jnumed.123.265921
    3. The Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy
      The Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy
      Amir Karimzadeh, Matthias Heck, Robert Tauber, Esteban Solaris, Stephan Nekolla, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1252-1258; DOI: https://doi.org/10.2967/jnumed.122.265346
Back to top

In this issue